News

Healthcare

Staff Reporter

, Singapore

Published:

1 year ago

302 views

(From left to right) Beh Kian Teik (Chief Executive, A*STAR), Dr Tan See Leng (Minister for Manpower and Second Minister for Trade and Industry), Soh Leng Wan (Assistant Managing Director (Manufacturing), Enterprise SG), Choo Heng Tong (Executive Vice President, EDB), Wong Anwei (Executive Director, Singapore Precision Engineering and Technology Association (SPETA)).

MedTech Catapult opens in Biopolis

It supports MedTech innovators in bringing products to market and connecting with local manufacturers.

MedTech Catapult, a national initiative led by A*STAR, has launched at Biopolis.

This $38m initiative, first announced during the Committee of Supply debate in March 2024, aims to accelerate the development and commercialisation of high-value life science instruments and medical devices.

“Through purposeful productisation, our national platforms such as MedTech Catapult guide MedTech innovations from ideation to regulatory approval and scalable manufacturing, ensuring they are market-ready,” said Irene Cheong, assistant chief executive (Innovation & Enterprise) at A*STAR.

In its first year, MedTech Catapult has supported projects such as Castomize’s Remouldable Orthopaedic Cast (4D-printed remouldable short arm cast for wrist fractures) and Dornier MedTech’s Smart System for Enhanced Laser Lithotripsy (kidney stone treatment).

In addition, MedTech Catapult unveiled a local supplier and contract manufacturer directory titled “Medtech Manufacturing in Singapore: A Commitment to Engineering Excellence.”

This directory, jointly supported by the Ministry of Trade and Industry, A*STAR, Enterprise Singapore (EnterpriseSG), the Singapore Economic Development Board, and the Singapore Precision Engineering and Technology Association, highlights the differentiated capabilities of local manufacturers.

It provides an overview of local capabilities, aiding medtech product owners to find potential local partners for co-innovation opportunities and scaling production efficiently. Additionally, it will be regularly updated to connect medtech innovators to the right manufacturing partners.

Follow the link for more news on

A*STAR

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia